Maravai LifeSciences Holdings, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
Maravai LifeSciences Holdings, Inc. (MRVI) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $3.23 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-07
- Maravai LifeSciences Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $1.63M, a 27.10% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $1.61M, a 26.57% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $2.29M, a 6.02% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $2.26M, a 7.37% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $8.96M, a 5.67% increase from fiscal 2024.
- Maravai LifeSciences Holdings, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $8.48M, a 0.53% decline from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $8.53M, a 36.04% increase from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $6.27M, a 28.71% decline from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $3.23M 10-Q · filed 2026-08-07 | $5.52M derived: sum of 3 quarters · filed 2026-08-07 | $7.78M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $1.61M 10-Q · filed 2026-05-08 | $3.89M derived: sum of 2 quarters · filed 2026-05-08 | $6.15M derived: sum of 3 quarters · filed 2026-05-08 | $8.38M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.55M derived: sum of 2 quarters · filed 2026-02-26 | $6.78M derived: sum of 3 quarters · filed 2026-08-07 | $8.96M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $4.49M derived: sum of 2 quarters · filed 2026-08-07 | $6.67M 10-Q · filed 2025-11-07 | $8.83M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $4.42M 10-Q · filed 2026-08-07 | $6.57M derived: sum of 3 quarters · filed 2026-08-07 | $8.68M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $2.19M 10-Q · filed 2026-05-08 | $4.34M derived: sum of 2 quarters · filed 2026-05-08 | $6.45M derived: sum of 3 quarters · filed 2026-05-08 | $8.57M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.26M derived: sum of 2 quarters · filed 2026-02-26 | $6.38M derived: sum of 3 quarters · filed 2026-02-26 | $8.48M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $4.23M derived: sum of 2 quarters · filed 2025-11-07 | $6.32M 10-Q · filed 2025-11-07 | $8.50M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $4.22M 10-Q · filed 2025-08-11 | $6.40M derived: sum of 3 quarters · filed 2026-02-26 | $8.55M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $2.10M 10-Q · filed 2025-05-12 | $4.28M derived: sum of 2 quarters · filed 2026-02-26 | $6.43M derived: sum of 3 quarters · filed 2026-02-26 | $8.56M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.33M derived: sum of 2 quarters · filed 2026-02-26 | $6.46M derived: sum of 3 quarters · filed 2026-02-26 | $8.53M 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $4.29M derived: sum of 2 quarters · filed 2024-11-12 | $6.35M 10-Q · filed 2024-11-12 | $8.18M derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-06-30 | $2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $4.19M 10-Q · filed 2024-08-08 | $6.02M derived: sum of 3 quarters · filed 2025-03-18 | $7.82M derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-03-31 | $2.06M 10-Q · filed 2024-05-09 | $3.89M derived: sum of 2 quarters · filed 2025-03-18 | $5.69M derived: sum of 3 quarters · filed 2025-03-18 | $6.46M derived: sum of 4 quarters · filed 2025-03-18 |
| 2022-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $3.63M derived: sum of 2 quarters · filed 2025-03-18 | $4.39M derived: sum of 3 quarters · filed 2025-03-18 | $6.27M 10-K · filed 2025-03-18 |
| 2022-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $2.56M derived: sum of 2 quarters · filed 2023-11-08 | $4.44M 10-Q · filed 2023-11-08 | $8.12M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $765.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $2.64M 10-Q · filed 2023-08-08 | $6.32M derived: sum of 3 quarters · filed 2024-02-29 | $7.92M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $1.87M 10-Q · filed 2023-05-09 | $5.55M derived: sum of 2 quarters · filed 2024-02-29 | $7.16M derived: sum of 3 quarters · filed 2024-02-29 | $8.29M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $3.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $5.28M derived: sum of 2 quarters · filed 2024-02-29 | $6.41M derived: sum of 3 quarters · filed 2024-02-29 | $8.79M 10-K · filed 2024-02-29 |
| 2021-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $2.73M derived: sum of 2 quarters · filed 2022-11-04 | $5.11M 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $3.51M 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | $2.38M 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 |